Sunday, December 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Xometry Projects Strong Start and Growth for 2024

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Xometry is projecting a strong start to the year, with expected revenue in Q1 2024 ranging from $118 million to $120 million, marking a 12%-14% increase from the previous year. The company also predicts an Adjusted EBITDA loss of $7.0-$9.0 million for the same period.

Looking further into fiscal 2024, Xometry is optimistic about marketplace revenue, forecasting a growth of at least 20% year-over-year. However, supplier services revenue is expected to decline by approximately 10% due to the discontinuation of certain sales and services.

Xometry’s goal for 2024 is to achieve Adjusted EBITDA profitability by the third quarter, with improved operating leverage helping to offset investments in international and enterprise growth.

XMTR Stock Shows Modest Increase on February 29, 2024

On February 29, 2024, XMTR stock showed positive performance, closing at $30.61, which was a $0.22 increase from the previous market close. This represented a 0.72% rise in the stock price. Despite the positive performance during regular trading hours, XMTR stock remained unchanged in after-hours trading. This suggests that investors may be taking a cautious approach towards the stock. Overall, XMTR stock showed a modest increase on February 29, 2024, reflecting a positive sentiment among investors. Investors should continue to monitor market trends and company developments to make informed decisions regarding XMTR stock.

XMTR Stock Performance Analysis: Revenue Growth but Decline in Net Income and EPS – February 29, 2024

On February 29, 2024, XMTR stock had a mixed performance based on the financial data provided by CNN Money. The company reported a total revenue of $381.05 million for the past year, showing a significant increase of 74.53% compared to the previous year. Additionally, the total revenue for the third quarter of the fiscal year was $118.93 million, indicating a 7.13% increase from the previous quarter.

XMTR reported a net income of -$76.03 million for the past year, which represents a 23.86% decrease compared to the previous year. The net income for the third quarter was -$12.02 million, showing a 54.72% increase from the previous quarter.

In terms of earnings per share (EPS), XMTR reported a negative EPS of -$1.61 for the past year, marking a 22.59% decrease from the previous year. The EPS for the third quarter was -$0.25, indicating a 54.85% increase from the previous quarter.

Overall, the financial performance of XMTR on February 29, 2024, reflected a mixed bag of results. While the company experienced significant revenue growth, there were declines in net income and EPS compared to the previous year. However, the positive growth in net income and EPS from the previous quarter suggests that XMTR may be on a path to recovery. Investors will need to closely monitor the company’s financial performance in the coming quarters to assess its long-term prospects.

Tags: XMTR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ blue chart

Barclays Analyst Adjusts Price Target for Oceaneering International

Healthcare cloud based

GH Research Reports Significant Net Loss in Second Quarter of 2023

Finances and charts

Demystifying the EB-5 Journey: Understanding Costs and Fees

Recommended

JD.com Stock

Pivotal Week Ahead for JD.com as Major European Acquisition and EV Launch Converge

2 months ago
Snowflake Stock

Snowflake Faces Investor Confidence Test After Executive’s Rogue Forecast

2 months ago
Fiserv Stock

Fiserv’s Strategic Expansion Meets Legal Scrutiny

3 months ago
Does_Walmart_Take_Google_Pay

Does Walmart Take Google Pay? Exploring Walmart’s Exclusive Payment Solution

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Bitcoin Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

Strategy Inc. Faces a Critical Index Classification Decision

DeFi Technologies Broadens Global Reach with New Listings and Products

Barrick Gold Secures Key Resolution in Mali, Paving Way for Mine Restart

Analyst Upgrade Sends Red Cat Shares Soaring

A Billion-Dollar Vote of Confidence for Standard Lithium

Trending

Tesla Stock
Automotive & E-Mobility

Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push

by Dieter Jaworski
December 21, 2025
0

Tesla shares are trading near their 52-week high as the company approaches a pivotal week, fueled by...

Wolfspeed Stock

Wolfspeed Secures Financial and Strategic Milestones

December 21, 2025
Textron Stock

Textron Stock Approaches Annual Peak Amid Strategic Wins

December 21, 2025
Intellia Therapeutics Stock

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

December 21, 2025
Strategy Stock

Strategy Inc. Faces a Critical Index Classification Decision

December 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push
  • Wolfspeed Secures Financial and Strategic Milestones
  • Textron Stock Approaches Annual Peak Amid Strategic Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com